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Objectives: Newer microbiologic methods to determine the species of coagulase-
negative staphylococci (CoNS) have evolved which have shown that most endocarditis
due to CoNS is caused by Staphylococcus epidermidis, and far fewer by Staphylococcus
warneri and Staphylococcus lugdunensis.
Methods: The recent opportunity to successfully treat a patient with methicillin-
resistant Staphylococcus capitis endocarditis secondary to an infected transvenous
pacemaker led to a review of the literature relating to S. capitis endocarditis.
Results: Thirteen previously recorded patients were identified. Twelve (86%) patients
were male. Ten had endocarditis associated with a native valve, two with prosthetic
valves and one with a transvenous pacemaker. Mortality was low in all 14 cases
(including this case report) with only two deaths; one in a patient with a native valve
and the other with a prosthetic valve. Four of the isolates were methicillin resistant
but sensitive to vancomycin, which was used in the treatment of eight patients. Those
patients with prosthetic cardiac devices appear to do better when the devices are
surgically removed.* Corresponding author. Tel.: +1 760 346 5688; fax: +1 760 773 3976.
E-mail address: laconemedico@aol.com (L.A. Cone).
1201-9712/$30.00 # 2005 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
doi:10.1016/j.ijid.2004.08.004
336 L.A. Cone et al.Conclusions: CoNS as a cause of endocarditis appears to be increasing and the current
ability to determine the species of these organisms should elicit the epidemiology,
clinical characteristics and biomolecular mechanisms involved in the induction of
valvular disease.
# 2005 International Society for Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.Introduction
In the years prior to the availability of valve repla-
cement surgery, infection of native heart valves by
coagulase-negative staphylococci (CoNS) was stated
to occur in between 1—10% of patients with infec-
tive endocarditis.1—3 With the development of both
prosthetic valve replacement and transvenous pace-
makers in the 1970s, the incidence of infective
endocarditis due to CoNS has become common,
constituting over 50% of such infections at the pre-
sent time4,5 and may at times consist of several
genetically different clones.6
For many years CoNS were grouped together as a
single species, Staphylococcus albus. Recent studies
have suggested that certain species of CoNS such as
S. epidermidis1,7 and S. lugdenensis1,8—10 are more
frequent causes of infective endocarditis. The
authors recently observed a patient with S. capitis
endocarditis secondary to an implanted pacemaker.
Thirteen previously-reported patients with S. capitis
endocarditis were also reviewed.11—21Case report
An 80-year-old white male underwent transvenous
pacemaker placement in 1987 and again in February
2002. Aside from previous orthopedic surgery
20 years earlier, he had not undergone any other
surgical procedures nor did he take medication
regularly. He claimed he had not felt well since
his last pacemaker insertion. For the last 3 to 4
months he noted occasional episodes of fever and
experienced persistent fatigue and malaise. He also
lost ten pounds. As a result of these complaints the
patient was admitted to the Eisenhower Medical
Center on 20 May 2002. Aside from a grade 2/6
apical systolic murmur and a pallid appearance,
physical examination was unremarkable. Laboratory
studies showed only a normocytic, normochromic
anemia and modest elevations of the sedimentation
rate and C-reactive protein. Three blood cultures
drawn on admission to the hospital grew S. capitis
after 72 hours of incubation. The colonies on blood
agar were noted to be tiny. Sensitivity studies
showed the organism to be methicillin resistant
but sensitive to vancomycin and rifampin.The patient was begun on 1 g of vancomycin
intravenously daily, and peak and trough blood
levels drawn 15 minutes before and 60 minutes per-
iodically after drug infusion were consistently ther-
apeutic. Within 48 hours he felt better and his
temperature elevation, which had been as high as
38.5 8C, resolved. A transthoracic echocardiogram
was non-diagnostic but a transesophageal echocar-
diogram was suspicious for vegetations on the pace-
maker leads. On 1 June 2002 the patient underwent
removal of the implanted transvenous pacemaker
and pacemaker leads, and placement of new epi-
cardial leads with an abdominal pacemaker implant.
At surgery he was found to have an infected
pacemaker lead with vegetations extending into
the tricuspid valve. The valve appeared severely
damaged with gross destruction of the chordae to
both the septal and anterior leaflets necessitating
porcine valve replacement. Cultures taken during
surgery from the transvenous pacemaker lead later
grew S. capitis. His postoperative course was
uneventful. He was continued on vancomycin at
the same dosage for a total of six weeks and fol-
low-up blood cultures carried out monthly for six
months were sterile.Discussion
Less than 25 years after William OsIer22 described
endocarditis in his Goulstonian Lectures, Lenhartz23
in 1901 recorded a case of S. albus endocarditis.
Thirty years later, Thayer24 noted an incidence of S.
albus endocarditis in 1.96% of 306 cases of infective
endocarditis observed over 40 years at the Johns
Hopkins Hospital. In 1951 Cates and Christie
described a 1.0% incidence of S. albus endocardi-
tis.25 With the advent of mitral valvulotomy in the
1950s and later with prosthetic heart valve replace-
ment and transvenous pacemakers, CoNS became
major pathogens causing endocarditis in these
patients.4,5,26
Staphylococcus epidermidis is the CoNS species
most often isolated; in recent series it constituted
up to 91% of the isolates.1,5,7 Staphylococcus war-
neri27 and S. lugdunensis1,7—10 have also been
recorded etiologies of infective endocarditis caused
by CoNS. Together with coryneforms, CoNS consti-
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other mammals.28 Staphylococcus capitis is part of
the normal flora of the skin of the scalp, face, ears
and neck.29 Staphylococcus capitis is divided into
two subspecies: subspecies capitis and subspecies
ureolyticus. Staphylococcus capitis accounts for
5% of pathogenic isolates of CoNS, and has been
shown to cause pneumonia, urinary tract infection,
catheter-related bacteremia and cellulitis.28,30
Infective endocarditis due to S. capitis has thus
far been described in 13 patients. All but three have
involved native valves with two infecting prosthetic
valves and a single case of infection in an implanted
transvenous pacemaker.11—25 Twelve of all 14 (86%)
including this patient were male. These cases are
summarized in Table 1. Only two deaths were
recorded, one in a patient with a prosthetic valve
and the other in a patient with a native valve.
Although the number of cases of endocarditis due
to S. capitis is small, early removal of either a
prosthetic valve or infected pacemaker would
appear prudent,31 while native valve endocarditis
could successfully be treated with appropriate anti-
microbials alone.
Pacemaker infections occur in 15% of implanted
permanent pacemakers but the reported incidence
of pacemaker-related endocarditis varies from
0.13—7%.32—36 The large majority are due to
CoNS.26,28,29 Obviously, pacemaker-associated
infection does not always indicate simultaneous
endocarditis. Cacoub et al.37 reported a large seriesTable 1 Summary of 14 reported cases of Staphylococcus
Case Ref Age Sex Pacemaker Treatment
1 11 72 M Mitral Vancomycin, gentam
2 12 53 M Mitral Amoxacillin, netilm
ceftriaxone
3 13 63 M Tricuspid Cloxacillin
4 14 29 F Mitral Penicillin, gentamic
5 14 62 M Mitral Vancomycin, penici
rifampin pefloxacin
6 15 70 M Aortic Nafcillin, gentamic
7 16 65 F Mitral Imipenem, vancom
8 17 73 M Mitral Ampicillin, gentam
9 18 46 M Aortic Vancomycin, rifamp
10 18 35 M Aortic Vancomycin, rifamp




12 20 64 M Pacemaker Oxacillin, gentamic
pacemaker remove
13 21 79 M Aortic Vancomycin, nafcill
14 (PR) 80 M Pacemaker Vancomycin, valve
pacemaker remove
MRSA = methicillin resistant S. capitis; PR = present report.of 33 patients with definite pacemaker endocarditis
based upon surgery, autopsy or bacteriological find-
ings of valvular vegetations or electrode-tip wire
vegetation. Seventy-five percent of patients were
>60 years of age. Although pouch hematoma or
inflammation was common (58%) other predisposing
factors for endocarditis were rare. Early infection
(<3 months) occurred in about 30% of patients and
late (>3 months) in the remainder. Fever was pre-
sent in 36% of patients and 24% manifested evidence
of chronic debilitating disease as in this case report.
Transthoracic echocardiography was a poor techni-
que to evaluate vegetations while transesophageal
echocardiography identified lead or valvular vege-
tations in 96% of patients that were tested. Staphy-
lococcus epidermidis was found in >50% of patients
and most often in early rather than late endocardi-
tis. Overall mortality was 24%.
Only a single case of a pacemaker-related endo-
carditis caused by S. capitis has been previously
described.20 In that patient, as well as in the one
described in this report, the pacemaker was
promptly removed with a successful outcome.
In the current patient, the clinical course could be
termed subacute, while in others it can be acute,
resembling S. aureus infections.1 Endocarditis asso-
ciated with CoNS has been noted to present with a
clinical picture of an acute endocarditis in 25% of
patients,1 perhaps secondary to certain exotoxins it
shares with S. aureus. However, the majority of
patients with endocarditis due to CoNS usuallycapitis endocarditis.
Outcome Complications MRSA
icin Survived None Yes
icin, Survived Embolus No
Survived Heart failure No




in Survived None No
ycin Survived Valve replacement Yes
icin, cloxacillin Died neurologic No
in Survived Amputation No















338 L.A. Cone et al.present with a subacute picture more reminiscent of
endocarditis due to the viridans streptococci.1,17 In
the current patient with S. capitis endocarditis, the
colonies that grew on blood agar were very tiny and
required 72 hours to grow. Although auxotrophism
studieswerenotperformedon the isolatedorganism,
its slow growth and small colony appearance suggest
that they are small colony variants (SCVs). It is gen-
erally assumed that S. capitisand the SCVs respond to
nafcillin, cephalosporins and vancomycin with or
without rifampin. However, methicillin (and thus
nafcillin) resistance, although uncommon with
S. capitis isolates, has been reported11,18 and was
present in this patient.Methicillin-resistant strains of
CoNS are most often found in patients with urinary
tract infections, meningitis and endocarditis.28 Of all
14 patients with endocarditis due to S. capitis, eight
received vancomycin and only one died. Of the
remainder who received penicillins and or cephalos-
porins, only one died. Four strains (24%) were methi-
cillin-resistant.
With the current ability to establish specific spe-
cies of CoNS according to criteria defined by KIoos
and Schleifer29 it is now possible to specifically
categorize infection by these organisms in patients
with endocarditis. Not only will the epidemiology,
clinical presentations and therapeutic options be
elicited, but the microbiologic mechanisms involved
in the initiation and progression of endocarditis will
likely be further defined.Acknowledgements
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